Home
ARVDnet
back

logo

  Contents:
  Clinical Features
  Epidemiology
  ARVD and Sport
  Genetics
  Molecular Genetics
  Therapy
  References
  Textbook on ARVD
  ARVD Scientists
  Diagnostic Centers
  Research in Padua
  Support Groups

  Discussion Forum



 


Therapy

Medical therapy with sotalol or amiodarone, or combination therapy (Class Ic drugs plus beta-blocking drugs, or amiodarone plus beta-blocking drugs) is frequently effective in preventing recurrent ventricular tachycardia. Ablation using radiofrequency (RF) or direct current (DC) energy is reserved for patients who are unresponsive or intolerant of antiarrhythmic drugs.
Ventricular arrhythmia recurrence of different morphology is not uncommon after apparent successful ablation. There appears to be a lower rate of successful ablation using RF energy. However, patients with this condition who have been resuscitated from sudden cardiac death or those refractory to medical treatment are candidates for ablation, implantation of an automatic cardioverter defibrillator, or cardiac transplantation. Surgery consisting of total disconnection of the right ventricle is a promising therapeutic modality. (Marcus & Fontaine, 1995).

 
             
         
  About this page:
Revisor:  Prof. G.A.Danieli.
Last update:  May, 6th, 2003.

 
Layout & programming by Fabio d'Alessi, 1999
   
Questions?  Write to the Webmaster